Major players in the ultraviolet-visible spectroscopy market are Shimadzu Corporation, Agilent Technologies, Thermo Fisher Scientific Inc., PerkinElmer Inc., Bio-Rad Laboratories, Hitachi High-Technologies Corporation, Buck Scientific, Bruker Corporation, Mettler-Toledo, Cole-Parmer, GBC Scientific Equipment, Hach Company, HORIBA. Ltd, Hamamatsu Photonics K.K, Analytik Jena, GBC Scientific Equipment, Biochrom, Ametek Process Instruments, Cecil Instrument, and GE Healthcare.
The global ultraviolet-visible spectroscopy market is expected to grow from $0.95 billion in 2020 to $1.01 billion in 2021 at a compound annual growth rate (CAGR) of 5.8%. The growth is mainly due to growing application and use of UV/visible spectroscopy in pharmaceutical & biotechnology environmental screening and other applications. The technological advancements and increasing need for food analysis and quality products is also adding to the growth of the market. The market is expected to reach $1.22 billion in 2025 at a CAGR of 4.8%.
The ultraviolet-visible spectroscopy market consists of sales of ultraviolet-visible spectroscopy products and related services by entities (organizations, sole traders and partnerships) that manufacture ultraviolet-visible spectroscopy devices.Ultraviolet-visible spectroscopy is a method used to measure light absorbance in the ultraviolet and visible ranges of the electromagnetic spectrum.
These devices find their application in analytical chemistry for the quantitative determination of different analytes, such as transition metal ions, highly conjugated organic compounds, and biological macromolecules.
The different types of the instruments included in ultraviolet-visible spectroscopy are single-beam system, double-beam system, array-based system and handheld system.Single-beam system utilizes one beam of light that passes through the sample and the intensity of the light reflected from a reference is measured without the sample.
Double-beam spectroscopes calculate the sample and conduct blank adjustments using the sample and reference beams.Array-based system use array detectors that can simultaneously acquire an entire spectral image over a finite spectral region.
Handheld systems allow researchers to analyze samples on the spot. Ultraviolet visible spectroscopy is implemented in wide range of verticals such as pharmaceutical and biotechnology companies, academic and research institutes, agriculture and food industries, environmental testing labs and is used in industrial applications, physical chemistry studies, life science studies, environmental studies, academic applications, life science research and development, quality assurance and quality control.
North America was the largest region in the ultraviolet-visible spectroscopy market in 2020.Asia Pacific is expected to be the fastest growing region in the forecast period.
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The companies in the market are increasingly investing in handheld or portable ultraviolet-visible spectroscopy market, which allows consumers to take informed decisions on the spot, thus saving valuable time.Major companies operating in the ultraviolet-visible spectroscopy sector are focused on developing portable technological solutions for ultraviolet-visible spectroscopy.
For instance, in December 2019, Shimadzu, a Japanese analytical instrumentation company, launched six new UV-VIS spectrophotometer models under the UV-i Selection brand, which have improved portability amongst other characteristics.The six UV-i Range models are SolidSpec-3700i, UV-2700i, UV-1900i, UV3600i Plus, SolidSpec-3700i DUV and UV-2600i.
UV-i Selection systems are ideal for a number of applications, including, pharmaceuticals, chemicals and academics.
In April 2020, Wiley, a USA based company that focuses on academic publishing and instructional materials acquired Bio-Rad Laboratories informatics products including the company spectroscopy software and spectral databases for an undisclosed amount.This acquisition adds expertise, content, and powerful software to Wiley science solutions segment.
Bio-Rad Laboratories is a USA based manufacturer and distributor of life science research products, clinical diagnostics, and analytical instrumentation.
The outbreak of COVID-19 led to increase in production of pharmaceutical drugs and demand for vaccines and fueled the growth of the ultraviolet-visible spectroscopy market.Due to increased demand for certain drugs during the pandemic, the demand of ultraviolet-visible spectroscopy instruments also grew for research and development of new medications and vaccines.
UV Vis spectrophotometry provides fast, easy and accurate characterization of components such as nucleic acids, proteins, additives/preservatives and can impact the time-to-result for both downstream and upstream processes including quality control. According to a study by Mettler Toledo, these instruments were extremely crucial for the development of the COVID-19 vaccines, and thus supported the growth of the market.
The countries covered in the ultraviolet-visible spectroscopy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.
Our reports have been used by over 10K customers, including:
128 pages •
By Asia Market Information & Development Company
• Aug 2021
This study focuses on China’s Caps and Closures industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is...
The global Raman spectroscopy market is projected to reach USD 861 million by 2026 from an estimated USD 602 million in 2021, at a CAGR of 7.4% from 2021 to 2026. The Rise in adoption of Raman spectroscopy in clinical applications and advancement in utilization of Raman spectroscopic techniques for catalysts and catalytic reactions are among...
The global single-use bioreactors market is projected to reach USD 8.8 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 21.1% during the forecast period. Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption,...
Real-world data and real-world evidence are used to monitor the post-market safety and adverse events of drugs.The monitoring of this data assists in making regulatory decisions. The healthcare community is using RWE and RWD to support coverage decisions and to develop guidelines and decision support tools for use in clinical practice. The...
The global laboratory filtration market exhibited strong growth during 2015-2020. Filtration is a basic separation technique that is used for removing solid particles from liquids or gaseous fluids. The primary components of a filter include a filter medium and a housing or holder that contains the sample, as well as...
Glucose Dependent Insulinotropic Receptor - Drugs In Development, 2021 Summary Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - G protein-coupled receptor 119 also known as GPR119 is a G protein-coupled receptor that is encoded by the GPR119 gene. GPR119 is expressed...
The thermal pallet covers market was valued at US$ 4,599.65 million in 2021 and is projected to reach US$ 10,469.73 million by 2028; it is expected to grow at a CAGR of 12.5% from 2021 to 2028. Thermal pallet covers safeguard temperature-sensitive goods from the effects of harsh weather and decrease the risk of excursions.The heat transmission...
Global Big Pharma Partnering Terms and Agreements 2014 to 2021 report provides a detailed understanding and analysis of how and why companies enter Big Pharma partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes. This report provides...
Global Specialty Pharmaceutical Partnering Terms and Agreements 2014 to 2021 report provides a detailed understanding and analysis of how and why companies enter Specialty Pharmaceutical partnering deals. This report provides details of the latest Specialty Pharmaceutical agreements announced in the life sciences since...
Retinoic Acid Receptor Gamma - Drugs In Development, 2021 Summary Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Retinoic acid receptor gamma (RARG) is a nuclear receptor that is encoded by the RARG gene. RARG bind as heterodimers to the...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.